Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Interference and Synergy of Anti-Circumsporozoite Antibodies on GA2-induced Immunity
2026-525353-37-00Phase 2Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2026
- Countries
- 1
01
Overview
Phase 2 trial of GA2 in Falciparum malaria (PF), sponsored by Leiden University Medical Center. Planned start Aug 2026; status: authorised.
02
Drugs
GA2
03
Conditions
Falciparum malaria (PF)
Beyond the preview
Go deeper on 2026-525353-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525353-37-00.